Patients with hereditary haemorrhagic telangiectasia (HHT) who suffer from severe epistaxis (nosebleeds) or gastrointestinal bleeding may benefit from intravenous bevacizumab, according to a new study.
In severe HHT, malformed blood vessels in the...
6 years ago
Colchester Hospital University Foundation Trust (CHUFT) haematology department has been awarded the Clinical Service Excellence Programme award from Myeloma UK.
The award recognises the hospital’s commitment to providing superior treatment to myel...
6 years ago
